Most Cancer Claims Survive In Suit Over Weight Loss Drug
A Missouri federal judge has dismissed design defect claims against Arena Pharmaceuticals over its weight loss medication Belviq, but the drugmaker couldn't shake allegations that its negligence and inadequate warnings caused...To view the full article, register now.
Already a subscriber? Click here to view full article